...
首页> 外文期刊>BMC Infectious Diseases >Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark
【24h】

Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark

机译:丹麦初级保健中疑似尿路感染患者的耐药性大肠埃希菌患病率

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Escherichia coli is the most common pathogen causing Urinary Tract Infections (UTI). Data from the current National Surveillance program in Denmark (DANMAP) may not accurately represent the prevalence of resistant E. coli in primary care, because only urine samples from complicated cases may be forwarded to the microbiological departments at hospitals for diagnostic examination. The aim of this study was to assess the prevalence of resistant E. coli to the most commonly used antimicrobial agents in primary care in a consecutive sample of patients from general practice. Methods Observational study carried out from December 2014 to December 2015. Thirty-nine general practices from The Capital Region of Denmark included adult patients with urinary tract symptoms and suspected UTI. All urine samples were sent to the central laboratory Statens Serum Institut (SSI). Significant bacteriuria was interpreted according to the European Urinalysis Standards. Susceptibility testing was performed and interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) standards. Results From the 39 general practices 505 patients were recruited. Completed data were obtained from 485 (96%) patients. According to the European Urinalysis Standards, 261 (54%) patients had positive bacteriuria. The most common uropathogen in patients with uncomplicated (uUTI) and complicated (cUTI) urinary tract infection was E. coli 105 (69%) and 76 (70%), respectively. Eighty-two (45%) of 181 E. coli isolates were resistant to at least one of the tested antibiotics and 50 out of 82 isolates were resistant to two or more antimicrobial agents. The highest resistance-rate was found against ampicillin 34% (95% CI 24;42) in uUTI and 36% (24;46) in cUTI. There were no differences in the distribution of resistance between uncomplicated and complicated cases. The prevalence of resistance was similar to the one reported in DANMAP?2014. Conclusion In E. coli from uUTI there is high resistance rates to antimicrobial agents commonly used in primary care. There was no difference in the distribution of resistant E. coli in suspected uUTI vs cUTI. In Denmark, data from the National Surveillance program DANMAP can guide the decision for choice of antibiotic in patients with suspected UTI seeking care in primary care. Trial registration ClinicalTrials.gov NCT02249273 .
机译:背景技术大肠杆菌是引起尿路感染(UTI)的最常见病原体。当前丹麦国家监视计划(DANMAP)的数据可能无法准确地代表初级保健中耐药性大肠杆菌的患病率,因为只有复杂病例的尿液样本才能转交给医院的微生物部门进行诊断检查。这项研究的目的是评估从一般实践中连续抽取的患者样本中,对初级保健中最常用的抗菌药物耐药的大肠杆菌的患病率。方法2014年12月至2015年12月进行观察性研究。来自丹麦首都地区的39项常规做法包括成年患者的尿路症状和可疑的UTI。所有尿液样本均送往中央实验室史坦顿血清研究所(SSI)。根据欧洲尿液分析标准解释了重要的细菌尿。药敏试验根据欧洲抗菌药敏试验委员会(EUCAST)标准进行并进行了解释。结果从39种常规方法中招募了505例患者。从485名患者(96%)获得了完整的数据。根据欧洲尿液分析标准,有261名患者(54%)的尿尿菌阳性。未合并尿路感染(uUTI)和合并尿路感染(cUTI)的患者中最常见的尿路病原分别是大肠杆菌105(69%)和76(70%)。 181株大肠杆菌中有82株(45%)对至少一种测试的抗生素有抗药性,而82株中有50株对两种或多种抗菌剂有抗药性。在uUTI中对氨苄西林的耐药率最高,为34%(95%CI 24; 42),在cUTI中对氨苄西林的耐药率最高,为36%(24; 46)。在简单和复杂病例之间,耐药性分布没有差异。耐药率与DANMAP?2014中报道的耐药率相似。结论在来自uUTI的大肠杆菌中,对初级保健中常用的抗菌剂耐药率很高。在怀疑的uUTI与cUTI中,耐药性大肠杆菌的分布没有差异。在丹麦,来自国家监测计划DANMAP的数据可以指导疑似UTI寻求初级保健的患者选择抗生素的决定。试用注册ClinicalTrials.gov NCT02249273。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号